Request for Covid-19 Impact Assessment of this Report
The United States Bi-Specific Antibodies market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Bi-Specific Antibodies market, reaching US$ million by the year 2028. As for the Europe Bi-Specific Antibodies landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Bi-Specific Antibodies players cover Roche (Chugai), Amgen, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Bi-Specific Antibodies market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Fragment-Based Antibodies
IgG-Based Antibodies
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cancer
Haemophilia
Other Non-Cancer Diseases
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche (Chugai)
Amgen
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bi-Specific Antibodies Market Size 2017-2028
2.1.2 Bi-Specific Antibodies Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Bi-Specific Antibodies Segment by Type
2.2.1 Fragment-Based Antibodies
2.2.2 IgG-Based Antibodies
2.3 Bi-Specific Antibodies Market Size by Type
2.3.1 Bi-Specific Antibodies Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Bi-Specific Antibodies Market Size Market Share by Type (2017-2022)
2.4 Bi-Specific Antibodies Segment by Application
2.4.1 Cancer
2.4.2 Haemophilia
2.4.3 Other Non-Cancer Diseases
2.5 Bi-Specific Antibodies Market Size by Application
2.5.1 Bi-Specific Antibodies Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Bi-Specific Antibodies Market Size Market Share by Application (2017-2022)
3 Bi-Specific Antibodies Market Size by Player
3.1 Bi-Specific Antibodies Market Size Market Share by Players
3.1.1 Global Bi-Specific Antibodies Revenue by Players (2020-2022)
3.1.2 Global Bi-Specific Antibodies Revenue Market Share by Players (2020-2022)
3.2 Global Bi-Specific Antibodies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bi-Specific Antibodies by Regions
4.1 Bi-Specific Antibodies Market Size by Regions (2017-2022)
4.2 Americas Bi-Specific Antibodies Market Size Growth (2017-2022)
4.3 APAC Bi-Specific Antibodies Market Size Growth (2017-2022)
4.4 Europe Bi-Specific Antibodies Market Size Growth (2017-2022)
4.5 Middle East & Africa Bi-Specific Antibodies Market Size Growth (2017-2022)
5 Americas
5.1 Americas Bi-Specific Antibodies Market Size by Country (2017-2022)
5.2 Americas Bi-Specific Antibodies Market Size by Type (2017-2022)
5.3 Americas Bi-Specific Antibodies Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bi-Specific Antibodies Market Size by Region (2017-2022)
6.2 APAC Bi-Specific Antibodies Market Size by Type (2017-2022)
6.3 APAC Bi-Specific Antibodies Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bi-Specific Antibodies by Country (2017-2022)
7.2 Europe Bi-Specific Antibodies Market Size by Type (2017-2022)
7.3 Europe Bi-Specific Antibodies Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bi-Specific Antibodies by Region (2017-2022)
8.2 Middle East & Africa Bi-Specific Antibodies Market Size by Type (2017-2022)
8.3 Middle East & Africa Bi-Specific Antibodies Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Bi-Specific Antibodies Market Forecast
10.1 Global Bi-Specific Antibodies Forecast by Regions (2023-2028)
10.1.1 Global Bi-Specific Antibodies Forecast by Regions (2023-2028)
10.1.2 Americas Bi-Specific Antibodies Forecast
10.1.3 APAC Bi-Specific Antibodies Forecast
10.1.4 Europe Bi-Specific Antibodies Forecast
10.1.5 Middle East & Africa Bi-Specific Antibodies Forecast
10.2 Americas Bi-Specific Antibodies Forecast by Country (2023-2028)
10.2.1 United States Bi-Specific Antibodies Market Forecast
10.2.2 Canada Bi-Specific Antibodies Market Forecast
10.2.3 Mexico Bi-Specific Antibodies Market Forecast
10.2.4 Brazil Bi-Specific Antibodies Market Forecast
10.3 APAC Bi-Specific Antibodies Forecast by Region (2023-2028)
10.3.1 China Bi-Specific Antibodies Market Forecast
10.3.2 Japan Bi-Specific Antibodies Market Forecast
10.3.3 Korea Bi-Specific Antibodies Market Forecast
10.3.4 Southeast Asia Bi-Specific Antibodies Market Forecast
10.3.5 India Bi-Specific Antibodies Market Forecast
10.3.6 Australia Bi-Specific Antibodies Market Forecast
10.4 Europe Bi-Specific Antibodies Forecast by Country (2023-2028)
10.4.1 Germany Bi-Specific Antibodies Market Forecast
10.4.2 France Bi-Specific Antibodies Market Forecast
10.4.3 UK Bi-Specific Antibodies Market Forecast
10.4.4 Italy Bi-Specific Antibodies Market Forecast
10.4.5 Russia Bi-Specific Antibodies Market Forecast
10.5 Middle East & Africa Bi-Specific Antibodies Forecast by Region (2023-2028)
10.5.1 Egypt Bi-Specific Antibodies Market Forecast
10.5.2 South Africa Bi-Specific Antibodies Market Forecast
10.5.3 Israel Bi-Specific Antibodies Market Forecast
10.5.4 Turkey Bi-Specific Antibodies Market Forecast
10.5.5 GCC Countries Bi-Specific Antibodies Market Forecast
10.6 Global Bi-Specific Antibodies Forecast by Type (2023-2028)
10.7 Global Bi-Specific Antibodies Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche (Chugai)
11.1.1 Roche (Chugai) Company Information
11.1.2 Roche (Chugai) Bi-Specific Antibodies Product Offered
11.1.3 Roche (Chugai) Bi-Specific Antibodies Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche (Chugai) Main Business Overview
11.1.5 Roche (Chugai) Latest Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Bi-Specific Antibodies Product Offered
11.2.3 Amgen Bi-Specific Antibodies Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Amgen Main Business Overview
11.2.5 Amgen Latest Developments
12 Research Findings and Conclusion
Table 1. Bi-Specific Antibodies Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Fragment-Based Antibodies
Table 3. Major Players of IgG-Based Antibodies
Table 4. Bi-Specific Antibodies Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Bi-Specific Antibodies Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Bi-Specific Antibodies Market Size Market Share by Type (2017-2022)
Table 7. Bi-Specific Antibodies Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Bi-Specific Antibodies Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Bi-Specific Antibodies Market Size Market Share by Application (2017-2022)
Table 10. Global Bi-Specific Antibodies Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Bi-Specific Antibodies Revenue Market Share by Player (2020-2022)
Table 12. Bi-Specific Antibodies Key Players Head office and Products Offered
Table 13. Bi-Specific Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Bi-Specific Antibodies Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Bi-Specific Antibodies Market Size Market Share by Regions (2017-2022)
Table 18. Americas Bi-Specific Antibodies Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Bi-Specific Antibodies Market Size Market Share by Country (2017-2022)
Table 20. Americas Bi-Specific Antibodies Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Bi-Specific Antibodies Market Size Market Share by Type (2017-2022)
Table 22. Americas Bi-Specific Antibodies Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Bi-Specific Antibodies Market Size Market Share by Application (2017-2022)
Table 24. APAC Bi-Specific Antibodies Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Bi-Specific Antibodies Market Size Market Share by Region (2017-2022)
Table 26. APAC Bi-Specific Antibodies Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Bi-Specific Antibodies Market Size Market Share by Type (2017-2022)
Table 28. APAC Bi-Specific Antibodies Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Bi-Specific Antibodies Market Size Market Share by Application (2017-2022)
Table 30. Europe Bi-Specific Antibodies Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Bi-Specific Antibodies Market Size Market Share by Country (2017-2022)
Table 32. Europe Bi-Specific Antibodies Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Bi-Specific Antibodies Market Size Market Share by Type (2017-2022)
Table 34. Europe Bi-Specific Antibodies Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Bi-Specific Antibodies Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Bi-Specific Antibodies Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Bi-Specific Antibodies Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Bi-Specific Antibodies Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Bi-Specific Antibodies
Table 43. Key Market Challenges & Risks of Bi-Specific Antibodies
Table 44. Key Industry Trends of Bi-Specific Antibodies
Table 45. Global Bi-Specific Antibodies Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Bi-Specific Antibodies Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Bi-Specific Antibodies Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Bi-Specific Antibodies Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Bi-Specific Antibodies Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Bi-Specific Antibodies Market Size Market Share Forecast by Application (2023-2028)
Table 51. Roche (Chugai) Details, Company Type, Bi-Specific Antibodies Area Served and Its Competitors
Table 52. Roche (Chugai) Bi-Specific Antibodies Product Offered
Table 53. Roche (Chugai) Bi-Specific Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Roche (Chugai) Main Business
Table 55. Roche (Chugai) Latest Developments
Table 56. Amgen Details, Company Type, Bi-Specific Antibodies Area Served and Its Competitors
Table 57. Amgen Bi-Specific Antibodies Product Offered
Table 58. Amgen Main Business
Table 59. Amgen Bi-Specific Antibodies Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Amgen Latest Developments
List of Figures
Figure 1. Bi-Specific Antibodies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Bi-Specific Antibodies Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Bi-Specific Antibodies Market Size Market Share by Type in 2021
Figure 7. Bi-Specific Antibodies in Cancer
Figure 8. Global Bi-Specific Antibodies Market: Cancer (2017-2022) & ($ Millions)
Figure 9. Bi-Specific Antibodies in Haemophilia
Figure 10. Global Bi-Specific Antibodies Market: Haemophilia (2017-2022) & ($ Millions)
Figure 11. Bi-Specific Antibodies in Other Non-Cancer Diseases
Figure 12. Global Bi-Specific Antibodies Market: Other Non-Cancer Diseases (2017-2022) & ($ Millions)
Figure 13. Global Bi-Specific Antibodies Market Size Market Share by Application in 2021
Figure 14. Global Bi-Specific Antibodies Revenue Market Share by Player in 2021
Figure 15. Global Bi-Specific Antibodies Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Bi-Specific Antibodies Market Size 2017-2022 ($ Millions)
Figure 17. APAC Bi-Specific Antibodies Market Size 2017-2022 ($ Millions)
Figure 18. Europe Bi-Specific Antibodies Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Bi-Specific Antibodies Market Size 2017-2022 ($ Millions)
Figure 20. Americas Bi-Specific Antibodies Value Market Share by Country in 2021
Figure 21. Americas Bi-Specific Antibodies Consumption Market Share by Type in 2021
Figure 22. Americas Bi-Specific Antibodies Market Size Market Share by Application in 2021
Figure 23. United States Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Bi-Specific Antibodies Market Size Market Share by Region in 2021
Figure 28. APAC Bi-Specific Antibodies Market Size Market Share by Application in 2021
Figure 29. China Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Bi-Specific Antibodies Market Size Market Share by Country in 2021
Figure 36. Europe Bi-Specific Antibodies Market Size Market Share by Type in 2021
Figure 37. Europe Bi-Specific Antibodies Market Size Market Share by Application in 2021
Figure 38. Germany Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Bi-Specific Antibodies Market Size Market Share by Application in 2021
Figure 46. Egypt Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Bi-Specific Antibodies Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 52. APAC Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 53. Europe Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 55. United States Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 56. Canada Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 59. China Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 60. Japan Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 61. Korea Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 63. India Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 64. Australia Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 65. Germany Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 66. France Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 67. UK Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 68. Italy Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 69. Russia Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 70. Spain Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 73. Israel Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Bi-Specific Antibodies Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...